Jul 31, 2026 04:30AM

Apr 13, 2026 07:00AM

Mar 9, 2026 02:30AM

Feb 3, 2026 02:30AM

Oct 1, 2025 07:00AM

Oct 1, 2025 07:00AM

Sep 24, 2025 02:30AM ENHERTU® Plus Pertuzumab Granted Priority Review in the U.S. as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer

Jan 13, 2025 02:00AM

Oct 1, 2024 02:00AM

Apr 2, 2024 02:00AM

Feb 19, 2024 02:00AM

Jan 29, 2024 02:00AM

Dec 22, 2023 08:00AM

Apr 20, 2023 09:00PM Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA

Oct 24, 2022 08:00AM

Jul 25, 2022 02:00AM

Apr 19, 2022 02:00AM

15,649 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All